Part 1 A
|
No. |
Event |
General journal |
Debit |
Credit |
|
1 |
1 |
Warranty expense (2800000*3%)-31600 |
52400 |
|
|
Estimated warranty liability |
52400 |
|||
|
2 |
2 |
Bad debt expense (2800000*2%) |
56000 |
|
|
Allowance for uncollectible accounts |
56000 |
|||
|
3 |
3 |
Loss litigation |
2300000 |
|
|
Liability -litigation |
2300000 |
|||
|
4 |
4 |
No journal entry required |
||
|
5 |
5 |
Loss-product recall |
580000 |
|
|
Liability-product recall |
580000 |
|||
|
6 |
6 |
Promotional expense (70%*20*10800)-113000 |
38200 |
|
|
Estimated premium liability |
38200 |
Part 1 B
|
Event 1 |
No |
It is a warranty expense |
|
Event 2 |
No |
It is a bad debt expense |
|
Event 3 |
Yes |
It is a loss contingency. The appropriate disclosure is required including information occurring after the end of the year and before the financial statements are issued |
|
Event 4 |
Yes |
It is a gain contingency. Gain is recognized when it is actually received. Thus a disclosure is required |
|
Event 5 |
Yes |
It is a loss liability |
|
Event 6 |
No |
It is promotional expense |
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in...
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2021. Classical's fiscal year ends on December 31. Financial statements are issued in April 2022. 1. Classical's products carry a one-year warranty against manufacturer's defects. Based on previous experience, warranty costs are expected to approximate 3% of sales. Sales were $3.7 million (all credit) for 2021. Actual warranty expenditures were $49,400 and were recorded as warranty expense when incurred. 2. Although no customer...
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2021. Classical’s fiscal year ends on December 31. Financial statements are issued in April 2022. Classical’s products carry a one-year warranty against manufacturer’s defects. Based on previous experience, warranty costs are expected to approximate 2% of sales. Sales were $3.3 million (all credit) for 2021. Actual warranty expenditures were $22,800 and were recorded as warranty expense when incurred. Although no customer accounts have...
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2021. Classical's fiscal year ends on December 31. Financial statements are issued in April 2022. 1. Classical's products carry a one-year warranty against manufacturer's defects. Based on previous experience, warranty costs are expected to approximate 3% of sales. Sales were $2.3 million (all credit) for 2021. Actual warranty expenditures were $20,100 and were recorded as warranty expense when incurred. 2. Although no customer...
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2016. Classical's fiscal year ends on December 31. Financial statements are issued in April 2017. 1. Classical's products carry a one-year warranty against manufacturer's defects. Based on previous experience, warranty costs are expected to approximate 4% of sales. Sales were $2 million (all credit) for 2016. Actual warranty expenditures were $30,800 and were recorded as warranty expense when incurred. 2. Although no customer...
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2016. Classical's fiscal year ends on December 31. Financial statements are issued in April 2017. 1. Classical's products carry a one-year warranty against manufacturer's defects. Based on previous experience, warranty costs are expected to approximate 4% of sales. Sales were $2 million (all credit) for 2016. Actual warranty expenditures were $30,800 and were recorded as warranty expense when incurred. 2. Although no customer...
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2018. Classical's fiscal year ends on December 31. Financial statements are issued in April 2019. 1. Classical's products carry a one-year warranty against manufacturer's defects. Based on previous experience, warranty costs are expected to approximate 4 % of sales. Sales were $2.7 million (all credit) for 2018. Actual warranty expenditures were $43,500 and were recorded as warranty expense when incurred. 2. Although no customer accounts...
ctice Exercises Chapter 13 The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2021. Classical's fiscal year ends on December 31. Financial statements are issued in April 2022 1. Classical's products carry a one-year warranty against manufacturer's defects. Based on previous experience, warranty costs are expected to approximate 4% of sales. Sales were $2 million (all credit) for 2021. Actual warranty expenditures were $30,800 and were recorded as warranty expense when incurred....
Chapter 13 i Seved B The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2021. Classica's fiscal year ends on December 31. Financial statements are issued in April 2022. Jok int ences 1. Classical's products carry a one year warranty against manufacturer's defects. Based on previous experience, warranty costs are expected to approximate 4% of sales. Sales were $2.5 million (all credit) for 2021. Actual warranty expenditures were $40,000 and were recorded...
PLEASE PUT SOLUTION IN THE SAME FORMAT AS THE IMAGE.
THANK YOU!
Exercise 13-20 (Algo) Various transactions involving contingencles (LO13-5, 13-6) The following selected transactions relate to contingencles of Classical Tool Makers, Inc., which began operations In July 2021. Classical's fiscal year ends on December 31. Financial statements are issued in April 2022 1. Classical's products carry a one-year warranty against manufacturer's defects. Based on previous experience, warranty costs are expected to approximate 3% of sales. Sales were $2.3 million...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022 Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $16,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...